Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas.
Wang, Y
Sun, Q
Zhang, Y
Li, X
Liang, Q
Guo, R
Zhang, L
Han, X
Wang, J
Shao, L
Xue, Y
Yang, Y
Li, H
Nie, L
Shi, W
Liu, Q
Zhang, J
Duan, H
Huang, H
Luu, LDW
Tai, J
Yang, X
Wang, G
- Publisher:
- W B SAUNDERS CO LTD
- Publication Type:
- Journal Article
- Citation:
- J Infect, 2023, 86, (5), pp. 421-438
- Issue Date:
- 2023-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, Y | |
dc.contributor.author | Sun, Q | |
dc.contributor.author | Zhang, Y | |
dc.contributor.author | Li, X | |
dc.contributor.author | Liang, Q | |
dc.contributor.author | Guo, R | |
dc.contributor.author | Zhang, L | |
dc.contributor.author | Han, X | |
dc.contributor.author | Wang, J | |
dc.contributor.author | Shao, L | |
dc.contributor.author | Xue, Y | |
dc.contributor.author | Yang, Y | |
dc.contributor.author | Li, H | |
dc.contributor.author | Nie, L | |
dc.contributor.author | Shi, W | |
dc.contributor.author | Liu, Q | |
dc.contributor.author | Zhang, J | |
dc.contributor.author | Duan, H | |
dc.contributor.author | Huang, H | |
dc.contributor.author | Luu, LDW | |
dc.contributor.author | Tai, J | |
dc.contributor.author | Yang, X | |
dc.contributor.author | Wang, G | |
dc.date.accessioned | 2024-02-07T07:17:44Z | |
dc.date.available | 2023-03-28 | |
dc.date.available | 2024-02-07T07:17:44Z | |
dc.date.issued | 2023-05 | |
dc.identifier.citation | J Infect, 2023, 86, (5), pp. 421-438 | |
dc.identifier.issn | 0163-4453 | |
dc.identifier.issn | 1532-2742 | |
dc.identifier.uri | http://hdl.handle.net/10453/175436 | |
dc.description.abstract | Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) infection, is currently the deadliest infectious disease in human that can evolve to severe forms. A comprehensive immune landscape for Mtb infection is critical for achieving TB cure, especially for severe TB patients. We performed single-cell RNA transcriptome and T-cell/B-cell receptor (TCR/BCR) sequencing of 213,358 cells from 27 samples, including 6 healthy donors and 21 active TB patients with varying severity (6 mild, 6 moderate and 9 severe cases). Two published profiles of latent TB infection were integrated for the analysis. We observed an obviously elevated proportion of inflammatory immune cells (e.g., monocytes), as well as a markedly decreased abundance of various lymphocytes (e.g., NK and γδT cells) in severe patients, revealing that lymphopenia might be a prominent feature of severe disease. Further analyses indicated that significant activation of cell apoptosis pathways, including perforin/granzyme-, TNF-, FAS- and XAF1-induced apoptosis, as well as cell migration pathways might confer this reduction. The immune landscape in severe patients was characterized by widespread immune exhaustion in Th1, CD8+T and NK cells as well as high cytotoxic state in CD8+T and NK cells. We also discovered that myeloid cells in severe TB patients may involve in the immune paralysis. Systemic upregulation of S100A12 and TNFSF13B, mainly by monocytes in the peripheral blood, may contribute to the inflammatory cytokine storms in severe patients. Our data offered a rich resource for understanding of TB immunopathogenesis and designing effective therapeutic strategies for TB, especially for severe patients. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | W B SAUNDERS CO LTD | |
dc.relation.ispartof | J Infect | |
dc.relation.isbasedon | 10.1016/j.jinf.2023.03.020 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1103 Clinical Sciences | |
dc.subject.classification | Microbiology | |
dc.subject.classification | 3202 Clinical sciences | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Transcriptome | |
dc.subject.mesh | Tuberculosis | |
dc.subject.mesh | Mycobacterium tuberculosis | |
dc.subject.mesh | Latent Tuberculosis | |
dc.subject.mesh | Killer Cells, Natural | |
dc.subject.mesh | Killer Cells, Natural | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mycobacterium tuberculosis | |
dc.subject.mesh | Tuberculosis | |
dc.subject.mesh | Latent Tuberculosis | |
dc.subject.mesh | Transcriptome | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Transcriptome | |
dc.subject.mesh | Tuberculosis | |
dc.subject.mesh | Mycobacterium tuberculosis | |
dc.subject.mesh | Latent Tuberculosis | |
dc.subject.mesh | Killer Cells, Natural | |
dc.title | Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas. | |
dc.type | Journal Article | |
utslib.citation.volume | 86 | |
utslib.location.activity | England | |
utslib.for | 1103 Clinical Sciences | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | University of Technology Sydney/Faculty of Science/School of Life Sciences | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2024-02-07T07:17:42Z | |
pubs.issue | 5 | |
pubs.publication-status | Published | |
pubs.volume | 86 | |
utslib.citation.issue | 5 |
Abstract:
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) infection, is currently the deadliest infectious disease in human that can evolve to severe forms. A comprehensive immune landscape for Mtb infection is critical for achieving TB cure, especially for severe TB patients. We performed single-cell RNA transcriptome and T-cell/B-cell receptor (TCR/BCR) sequencing of 213,358 cells from 27 samples, including 6 healthy donors and 21 active TB patients with varying severity (6 mild, 6 moderate and 9 severe cases). Two published profiles of latent TB infection were integrated for the analysis. We observed an obviously elevated proportion of inflammatory immune cells (e.g., monocytes), as well as a markedly decreased abundance of various lymphocytes (e.g., NK and γδT cells) in severe patients, revealing that lymphopenia might be a prominent feature of severe disease. Further analyses indicated that significant activation of cell apoptosis pathways, including perforin/granzyme-, TNF-, FAS- and XAF1-induced apoptosis, as well as cell migration pathways might confer this reduction. The immune landscape in severe patients was characterized by widespread immune exhaustion in Th1, CD8+T and NK cells as well as high cytotoxic state in CD8+T and NK cells. We also discovered that myeloid cells in severe TB patients may involve in the immune paralysis. Systemic upregulation of S100A12 and TNFSF13B, mainly by monocytes in the peripheral blood, may contribute to the inflammatory cytokine storms in severe patients. Our data offered a rich resource for understanding of TB immunopathogenesis and designing effective therapeutic strategies for TB, especially for severe patients.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph